Transforming Diabetes Management with Eversense 365
Senseonics Holdings, Inc. is ushering in a new age of diabetes care with its innovative Eversense 365 Continuous Glucose Monitoring (CGM) system. This groundbreaking technology is designed for individuals living with diabetes, providing them with an option that extends glucose monitoring capabilities up to one year. This is a considerable improvement over traditional methods and marks a true evolution in how diabetes can be managed.
Upcoming Virtual Event Revealed
The company is set to host a unique virtual Key Opinion Leader (KOL) event aimed at discussing the potential and real-world applications of the Eversense 365 system. Scheduled for a date in late October, attendees will have the opportunity to engage with leading experts in diabetes care. Renowned endocrinologist David T. Ahn and Mercy's President of Specialty Service Lines, Jeff Ciaramita, will be leading the discussions, sharing their insights into how Eversense 365 can enhance diabetes management.
Highlights of the Eversense 365 System
The Eversense 365 is the first CGM system to offer continuous glucose measurement for an impressive one year. This advancement not only alleviates the burdens of frequent sensor changes but also provides a more stable and continuous view of glucose levels for individuals with Type 1 and Type 2 diabetes. With an intuitive design, the Eversense 365 continuously communicates via a smart transmitter that sends glucose data directly to a mobile app, ensuring users have timely access to their glucose readings and trends.
Company's Collaboration with Mercy Healthcare
One of the major highlights during the upcoming event will be Senseonics' collaboration with Mercy, a leading healthcare system known for providing exemplary patient care. This partnership aims to leverage Mercy's vast network and resources to encourage the adoption of the Eversense 365 system. Such collaborations are vital in broadening access to innovative diabetes care solutions, thus enhancing the overall patient experience.
Expert Insights Expected
A significant portion of the event will be dedicated to live interactions, allowing participants to pose questions to the panel of experts. This open dialogue is an invaluable opportunity for patients and healthcare professionals to gain clarity on practical applications of the Eversense 365 system in different clinical settings.
About Eversense
The Eversense CGM system is designed for adults aged 18 and older, providing actionable insights for diabetes management. It stands out as a prescription device that requires healthcare providers to assist with sensor insertion and removal. While the Eversense 365 system allows for extended use, patients still need to perform periodic fingerstick calibrations to ensure accuracy, typically once a week after a specified period.
About Senseonics Holdings, Inc.
Senseonics is a pioneering medical technology firm focused on improving diabetes management technologies. By creating long-term implantable glucose monitoring systems, Senseonics is dedicated to changing the lives of individuals living with diabetes. The Eversense 365 system not only enhances glucose monitoring but represents a significant innovation in well-being and health management.
Contact Information for Interested Parties
For more details regarding the Eversense 365 CGM system, interested parties can reach out to Senseonics' investor relations:
Jeremy Feffer
LifeSci Advisors
investors@senseonics.com
For inquiries related to Mercy's partnership or services, please contact:
Bethany Pope
Mercy Media Relations
314-251-4472
Bethany.Pope@Mercy.Net
Frequently Asked Questions
What is the Eversense 365 CGM system?
The Eversense 365 CGM system is a long-term glucose monitoring device that continuously measures glucose levels for up to a year.
When is the virtual KOL event scheduled?
The virtual KOL event will take place in late October, offering insights into the Eversense 365 system and its benefits.
Who will be speaking at the event?
The event will feature experts like Dr. David T. Ahn and Jeff Ciaramita, who will share their expertise on diabetes management.
How can one participate in the virtual event?
Interested individuals can register for the virtual event via the registration link provided by Senseonics.
What should participants expect from the event?
Attendees can expect informative presentations, expert insights on diabetes care, and a live Q&A session to engage directly with healthcare leaders.
